Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Episode 30 with Dr. Seema Tiwari-Woodruff on estrogenic compounds and MS
Randomized study combining interferon & glatiramer acetate in multiple sclerosis.
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
Tizanidine: Can Buy Uk
Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange.
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Episode 14 with Professor Gavin Giovannoni on the Epstein-Barr Virus (EBV).
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
Keystone Symposium: Mechanisms of Pro-Inflammatory Diseases - joint with - Innate Immunity and Determinants of Microbial Pathogenesis
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Immune Tolerance and Autoimmune Disease Conference
Episode 2 with Dr. Barbara Koppel on recommendations for cannabis in MS
Episode 32 with Dr. David Holtzman on the connection between MS and Alzheimer 's disease
Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.
Interferon beta-1b
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.
World Congress of Neurology (WCN) 2015
Association between beta-interferon exposure and hospital events in multiple sclerosis.
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.

Pages